NR3C2 and hydrops fetalis: The ARTS-HF (minerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure) (NCT01807221) trial involved patients with HFrEF with worsening chronic features requiring hospitalization and treatment with intravenous diuretics [27].